Skip to main content
H

HERON NEUTRON MEDICAL CORP. — Investor Relations & Filings

Ticker · 7799 LEI · 984500FDCFAACXT77020 TW Manufacturing
Open in API
Filings indexed 42 across all filing types
Latest filing 2026-04-14 Governance Information
Country TW Taiwan
Listing TW 7799

About HERON NEUTRON MEDICAL CORP.

https://www.heron-neutron.com/

Heron Neutron Medical Corp. specializes in the development and deployment of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) systems. The company provides end-to-end integrated solutions for oncology, encompassing the design and manufacture of high-precision accelerator systems, neutron beam moderators, treatment planning software, and treatment control systems. Its core technology facilitates targeted radiation therapy designed to maximize efficacy while minimizing treatment duration and side effects for cancer patients. Heron Neutron Medical is a pioneer in the commercialization of large-scale medical equipment, offering a comprehensive technology platform that includes both hardware and specialized boron-containing drugs. Through collaborations with clinical and academic institutions, the company focuses on establishing advanced BNCT centers to expand the availability of precision care and innovative cancer treatment options.

Recent filings

Filing Released Lang Actions
公司治理組織架構
Governance Information Classification · 1% confidence The document is a tabular disclosure of the company’s board structure (total directors, independent directors, audit and compensation committees, legal counsel, designated shareholder contact), not an earnings or financing update. It is not announcing a specific change in personnel but detailing the governance framework and board composition in accordance with corporate governance rules. This matches the “Governance Information” category (CGR).
2026-04-14 Chinese
115年04月法人說明會簡報 — 779920260410E001.pdf
Investor Presentation Classification · 1% confidence The document is explicitly titled “Investor Presentation” and contains slide-like content (agenda, company overview, market analysis, investment highlights), characteristic of a presentation deck prepared for investors. It is not a regulatory filing, earnings release, or report publication announcement but a detailed investor presentation. Therefore, the correct category is IP (Investor Presentation).
2026-04-10 English
115年04月法人說明會簡報 — 779920260410M001.pdf
Investor Presentation Classification · 1% confidence The document is a slide‐style presentation with an agenda, company overview, market analysis, investment highlights, product and financial slides, management bios, and contact details. It is structured as a pitch or investor deck rather than a formal regulatory filing or earnings release. Therefore, it fits the description of an Investor Presentation (IP).
2026-04-10 Chinese
115年04月法人說明會簡報
Investor Presentation Classification · 1% confidence The document is a listing of company’s upcoming ‘法人說明會’ (institutional investor presentations), with dates, locations, summary info, and links to the presentation PDFs. This clearly matches an Investor Presentation rather than a financial report or announcement of vote results. Therefore, it falls under Investor Presentation (IP).
2026-04-10 Chinese
本公司受邀參加寬量國際主辦之「19th QIC CEO Week」
Investor Presentation Classification · 1% confidence The document is a regulatory announcement on the Taiwan “公開資訊觀測站” detailing the company’s invitation to an institutional investors’ meeting (“法人說明會”) including date, time, location and high-level summary of topics (operations, financials and business information). It is not an AGM notice, earnings release, or full report but an announcement of an upcoming investor presentation event. The closest category in our taxonomy is “Investor Presentation” (IP).
2026-04-10 Chinese
本公司與長庚醫療財團法人林口長庚紀念醫院簽署硼中子 捕獲治療（BNCT）應用於乳癌臨床試驗計畫合作意向書
Regulatory Filings Classification · 1% confidence The document is a regulatory announcement submitted to Taiwan's Market Observation Post System (MOPS) disclosing a material cooperation agreement (a contract) between the company and a medical foundation. It is not a full report, financial statement, earnings release, dividend notice, M&A proposal, or management change, but a general regulatory disclosure of a contract. Thus it falls under the fallback category “Regulatory Filings (RNS).”
2026-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.